免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料，僅供一般參考，不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

CellDx-組織

K 號：K260235 · 2026-05-12

申請人Datar Cancer Genetics Private Limited
決定日期2026-05-12
產品代碼PZM
諮詢委員會PA
決定相當於

器材摘要

CellDx-Tissue is the device name listed in this FDA 510(k) record. The listed applicant is Datar Cancer Genetics Private Limited. It received FDA 510(k) clearance on 2026-05-12 under 510(k) number K260235. The device is classified under product code PZM. It was reviewed by the PA advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the CellDx-Tissue?

CellDx-Tissue is a medical device that received FDA 510(k) clearance on 2026-05-12. The listed applicant is Datar Cancer Genetics Private Limited. The 510(k) number is K260235.

When did CellDx-Tissue receive FDA 510(k) clearance?

CellDx-Tissue received FDA 510(k) clearance on 2026-05-12, under 510(k) number K260235.

Who is the listed applicant for CellDx-Tissue?

The FDA 510(k) record lists Datar Cancer Genetics Private Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CellDx-Tissue?

The FDA product code for CellDx-Tissue is PZM.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

NCT07608549FLASH 預試階段 1 安全性研究NOT_YET_RECRUITINGNCT06562205PAP系統外部臨床研究（ECS）NOT_YET_RECRUITINGNCT06443177對於動脈瘤性硬腦膜下出血引起的腦血管收縮，交感調節的影響SUSPENDEDNCT07095751人工智能協助的Uro-Cam導尿管評估系統，用於診斷膀胱癌NOT_YET_RECRUITING

相關器械（代碼：PZM）

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K241868xR IVDTempus AI, Inc.K250003GENESEEQPRIME NGS 癌症分析試劑 (FFPE) (GS6005)Geneseeq Technology, Inc.K210017ACTOnco，ACTOnco IVDAct GenomicsK202304紐約大學朗格尼基因PACT（可行癌症目標基因輪廓）Nyu Langone Medical CenterK192063PGDx elio 組織完整Personal Genome DiagnosticsK190661Omics CoreNanthealth, Inc.

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。

↑